Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001811645 | SCV001471240 | likely pathogenic | not provided | 2020-02-28 | criteria provided, single submitter | clinical testing | The CUBN c.1010C>T; p.Pro337Leu variant (rs202153130) is reported in the literature in multiple individuals affected with a hereditary vitamin B12 deficiency syndrome (Hauck 2008, Tanner 2012). Affected individuals with this variant have each been reported to carry an additional pathogenic variant (Tanner 2012), including one individual with a partial CUBN deletion confirmed in trans to p.Pro337Leu (Hauck 2008). The p.Pro337Leu variant is found in the non-Finnish European population with an overall allele frequency of 0.02% (29/129158 alleles) in the Genome Aggregation Database. The proline at codon 337 is highly conserved and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Based on available information, this variant is considered to be likely pathogenic. References: Hauck FH et al. Imerslund-Grasbeck syndrome in a 15-year-old German girl caused by compound heterozygous mutations in CUBN. Eur J Pediatr. 2008 Jun;167(6):671-5. Tanner SM et al. Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns. Orphanet J Rare Dis. 2012 Aug 28;7:56. |
MGZ Medical Genetics Center | RCV001095371 | SCV002580922 | likely pathogenic | Imerslund-Grasbeck syndrome type 1 | 2022-07-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002489738 | SCV002796632 | pathogenic | Imerslund-Grasbeck syndrome type 1; Proteinuria, chronic benign | 2022-03-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002555971 | SCV003223429 | pathogenic | Imerslund-Grasbeck syndrome | 2022-03-01 | criteria provided, single submitter | clinical testing | This missense change has been observed in individual(s) with Imerslund-Gräsbeck syndrome (PMID: 17668238, 22929189). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 873110). This variant is present in population databases (rs202153130, gnomAD 0.02%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 337 of the CUBN protein (p.Pro337Leu). |
Revvity Omics, |
RCV001811645 | SCV003828750 | uncertain significance | not provided | 2021-11-29 | criteria provided, single submitter | clinical testing | |
OMIM | RCV001095371 | SCV001250979 | pathogenic | Imerslund-Grasbeck syndrome type 1 | 2020-05-18 | no assertion criteria provided | literature only |